Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Anbio Biotechnology, the most common co-covered peer. The tracked stories average 3 original sources each. Oncocyte appears in 1 tracked Biotech story from February 22, 2026.
Last mentioned: Feb 22, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Anbio Biotechnology, the most common co-covered peer. The tracked stories average 3 original sources each. Oncocyte appears in 1 tracked Biotech story from February 22, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Oncocyte. Shared-story counts are live from our verified record — not editorial picks.
A detailed financial comparison between Anbio Biotechnology and Oncocyte highlights diverging paths in the biotech manufacturing sector. While both companies compete for institutional interest, their distinct risk profiles and valuation metrics offer different opportunities for healthcare investors.
Oncocyte is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
